Sign In
Buy CPRT
Copart Earnings Calls
| Release date | May 21, 2026 |
| EPS estimate | $0.406 |
| EPS actual | $0.430 |
| EPS Surprise | 5.83% |
| Revenue estimate | 1.195B |
| Revenue actual | 1.237B |
| Revenue Surprise | 3.54% |
| Release date | Feb 19, 2026 |
| EPS estimate | $0.393 |
| EPS actual | $0.360 |
| EPS Surprise | -8.28% |
| Revenue estimate | 1.149B |
| Revenue actual | 1.122B |
| Revenue Surprise | -2.36% |
| Release date | Nov 20, 2025 |
| EPS estimate | $0.390 |
| EPS actual | $0.410 |
| EPS Surprise | 5.21% |
| Revenue estimate | 1.179B |
| Revenue actual | 1.155B |
| Revenue Surprise | -2.01% |
| Release date | Sep 04, 2025 |
| EPS estimate | $0.361 |
| EPS actual | $0.410 |
| EPS Surprise | 13.48% |
| Revenue estimate | 1.137B |
| Revenue actual | 1.125B |
| Revenue Surprise | -1.03% |
Last 4 Quarters for Copart
Below you can see how CPRT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 04, 2025 |
| Price on release | $49.97 |
| EPS estimate | $0.361 |
| EPS actual | $0.410 |
| EPS surprise | 13.48% |
| Date | Price |
|---|---|
| Aug 28, 2025 | $48.75 |
| Aug 29, 2025 | $48.81 |
| Sep 02, 2025 | $48.48 |
| Sep 03, 2025 | $48.12 |
| Sep 04, 2025 | $49.97 |
| Sep 05, 2025 | $48.57 |
| Sep 08, 2025 | $48.75 |
| Sep 09, 2025 | $48.07 |
| Sep 10, 2025 | $48.52 |
| 4 days before | 2.50% |
| 4 days after | -2.90% |
| On release day | -2.80% |
| Change in period | -0.472% |
| Release date | Nov 20, 2025 |
| Price on release | $41.02 |
| EPS estimate | $0.390 |
| EPS actual | $0.410 |
| EPS surprise | 5.21% |
| Date | Price |
|---|---|
| Nov 14, 2025 | $41.08 |
| Nov 17, 2025 | $41.33 |
| Nov 18, 2025 | $41.32 |
| Nov 19, 2025 | $41.37 |
| Nov 20, 2025 | $41.02 |
| Nov 21, 2025 | $40.73 |
| Nov 24, 2025 | $38.91 |
| Nov 25, 2025 | $39.06 |
| Nov 26, 2025 | $38.75 |
| 4 days before | -0.146% |
| 4 days after | -5.53% |
| On release day | -0.707% |
| Change in period | -5.67% |
| Release date | Feb 19, 2026 |
| Price on release | $37.65 |
| EPS estimate | $0.393 |
| EPS actual | $0.360 |
| EPS surprise | -8.28% |
| Date | Price |
|---|---|
| Feb 12, 2026 | $36.72 |
| Feb 13, 2026 | $37.49 |
| Feb 17, 2026 | $37.52 |
| Feb 18, 2026 | $37.75 |
| Feb 19, 2026 | $37.65 |
| Feb 20, 2026 | $36.48 |
| Feb 23, 2026 | $35.36 |
| Feb 24, 2026 | $35.28 |
| Feb 25, 2026 | $35.84 |
| 4 days before | 2.53% |
| 4 days after | -4.81% |
| On release day | -3.11% |
| Change in period | -2.40% |
| Release date | May 21, 2026 |
| Price on release | $34.40 |
| EPS estimate | $0.406 |
| EPS actual | $0.430 |
| EPS surprise | 5.83% |
| Date | Price |
|---|---|
| May 15, 2026 | $32.30 |
| May 18, 2026 | $33.44 |
| May 19, 2026 | $33.12 |
| May 20, 2026 | $33.04 |
| May 21, 2026 | $34.40 |
| May 22, 2026 | $33.79 |
| May 26, 2026 | $33.24 |
| May 27, 2026 | $32.85 |
| May 28, 2026 | $33.28 |
| 4 days before | 6.50% |
| 4 days after | -3.26% |
| On release day | -1.77% |
| Change in period | 3.03% |
Copart Earnings Call Transcript Summary of Q2 2026
Copart reported Q2 FY2026 revenue of $1.12 billion, down 3.6% year-over-year (up 1.3% ex-CAT), with consolidated gross profit of $492.8 million and diluted EPS of $0.36 (down ~9%). Global unit volumes declined ~8% (insurance units down ~9% or ~4% ex-CAT); however, U.S. insurance average selling prices (ASPs) rose 6% (9% ex-CAT) and overall gross margin expanded to 45% (up 178 bps ex-CAT adjustments). International revenue grew (~6–8% ex-CAT) with strong noninsurance growth in the U.K. and Canada. Copart emphasized continued structural advantages: a large, liquid global buyer base, fastest cycle times (Title Express, tow network), and technology/AI deployment across the business to improve productivity and decisioning. Balance sheet strength remains a key theme: approximately $6.4 billion in liquidity (about $5.1 billion cash) and no debt; the company has repurchased >13 million shares (~$500M) fiscal year-to-date. Management reiterated disciplined capital allocation (select land investments to support long‑term capacity), focus on delivering superior economic outcomes to insurance clients, and a cautious but proactive approach to M&A (organic growth bias). Other notes: Purple Wave (heavy equipment) continues to grow, though tariffs disrupted that market; seasonality/cyclicality in insurance policy behavior and claims frequency are key near-term volume drivers.
